ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/09/2023
Voltar para busca
Dado oficial do USPTO
SOPHIA GENETICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SOPHIA GENETICS
ST13
US500000079230427Classe
5, 42
Pedido
79230427
Registro
6748985
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
23/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
20/12/2017
Data de registro
07/06/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/06/2022
Última transação
10/06/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
33
Localização do titular
CH
Examinador
AYALA, LOURDES
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SOPHiA GENETICS SA
SOPHiA GENETICS SA
Representantes
THOMAS J MANGO CANTOR COLBURN LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic reagents and contrast agents for medical use; chemical reagents for medical use; diagnostic biomarker reagents for diagnostics for medical use; kits containing various reagents for diagnostic tests for medical use
Classe 42
Conducting project feasibility studies in the field of new technologies and machine learning; technical research in the field of genomicsgenetics and bioinformaticsappraisals being genetic testing for scientific research purposes; writingdesigndevelopment and updating of computer software in the field of bioinformatics; technical support concerning the use of softwaretroubleshooting of computer software problems in the field of bioinformatics; Software as a service (SAAS) serviceshosting software for use by others to provide access to an online internet SaaS platform in the field of bioinformatics; provision of online nondownloadable software for use in database management and data analysis in the fields of genetics and genomics; platform as a service (PAAS) featuring computer software platforms enabling users to access softwarecomputer networkscomputer servers and computer and data storage systems and allowing the user to use them in the field of bioinformatics; provision of temporary use of non-downloadable software for importingmanagement and analysis of dataincorporating automatic learning and artificial intelligence components in the field of bioinformatics; provision of software (Software as a ServiceSAAS) featuring software for use in database management and data analysis in the fields of genetics and genomics; software as a service (SAAS) featuring software for automatic learning and artificial intelligence to be used for data analysis in the field bioinformatics; providing scientific information in the field of genetics and genomics research information via web-based platforms; electronic data storage and cloud computingcloud computing featuring software for use in database management for bioinformatics analysis; bioinformatic analysis services being chemical and biological analysis services; development of softwaredevelopment of software for data processing in the field of bioinformatics; scientific research featuring provision of methods and tools for calculations and bioinformatics for data analysis; development and maintenance of data management software; database design in the field of bioinformatics; computer software developmentdevelopment of software of genomic and bioinformatic mobile applications; electronic storage of data by computer in the field of bioinformatics; and provision of advice and information for the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/10/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
15/09/2022
FIMP
FINAL DISPOSITION PROCESSED
15/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/09/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
29/04/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/04/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
29/03/2022
OP.T
OPPOSITION TERMINATED NO. 999999
29/03/2022
OP.D
OPPOSITION DISMISSED NO. 999999
29/03/2022
RFNP
REFUSAL PROCESSED BY IB
03/01/2020
OP.I
OPPOSITION INSTITUTED NO. 999999
12/12/2019
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
10/12/2019
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
10/12/2019
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/10/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/09/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25/09/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/08/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/07/2019
PUBO
PUBLISHED FOR OPPOSITION
09/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/06/2019
ALIE
ASSIGNED TO LIE
30/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/04/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
22/04/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/10/2018
GNSL
LETTER OF SUSPENSION E-MAILED
16/10/2018
CNSL
SUSPENSION LETTER WRITTEN
16/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/09/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/09/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/09/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/09/2018
RFNT
REFUSAL PROCESSED BY IB
25/05/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/05/2018
RFRR
REFUSAL PROCESSED BY MPU
07/05/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2018
CNRT
NON-FINAL ACTION WRITTEN
02/05/2018
MAFR
APPLICATION FILING RECEIPT MAILED
27/04/2018
DOCK
ASSIGNED TO EXAMINER
23/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/04/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
20/04/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/04/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SOPHIA GENETICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.